


RESOLVE, Multishot Echoplanar Diffusion Weighted Imaging
Imaging Findings:
The RESOLVE sequence permits acquisition of multishot diffusion weighted echoplanar scans. This feature can be used in many ways, with a simplistic but very clinically relevant application illustrated. In particular at 3 T, bulk susceptibility artifacts can markedly degrade diffusion-weighted images, rendering them non-diagnostic. Acceptable image quality has been achieved to date at 3 T by using parallel imaging. This technique can decrease the impact of the susceptibility differences, which otherwise lead to substantial artifacts, in particular at the interface between the brain and air filled sinuses. The two scans illustrated show that multishot EPI (RESOLVE in this instance) can be used in the same manner as parallel imaging, with a similar (if not somewhat greater, in the current example) impact on bulk susceptibility artifact. By applying RESOLVE in the future in combination with parallel imaging, a further reduction in bulk susceptibility artifacts should be readily achieved (ISMRM 2006, p1046), bringing scans at 3 T in line with the quality of 1.5 T scans, at least in terms of the prominence of this artifact. RESOLVE will likely find application in a wide range of DWI and DTI examinations, which require diffusion-weighted images with a higher level of detail than that offered by current single-shot EPI scans.
Acknowledgment: these scans were acquired in collaboration with David Porter of Siemens Healthcare, Erlangen, Germany.
